nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—Neuritis—Epirubicin—liver cancer	0.0058	0.00583	CcSEcCtD
Naratriptan—Paralysis—Doxorubicin—liver cancer	0.00577	0.0058	CcSEcCtD
Naratriptan—Burning sensation—Doxorubicin—liver cancer	0.00577	0.0058	CcSEcCtD
Naratriptan—Neuralgia—Doxorubicin—liver cancer	0.00577	0.0058	CcSEcCtD
Naratriptan—Scotoma—Epirubicin—liver cancer	0.0057	0.00573	CcSEcCtD
Naratriptan—Hyperlipidaemia—Doxorubicin—liver cancer	0.00556	0.00559	CcSEcCtD
Naratriptan—Hyperaesthesia—Epirubicin—liver cancer	0.00552	0.00555	CcSEcCtD
Naratriptan—Feeling hot—Epirubicin—liver cancer	0.00552	0.00555	CcSEcCtD
Naratriptan—Tinnitus—Sorafenib—liver cancer	0.00549	0.00552	CcSEcCtD
Naratriptan—Cardiac disorder—Sorafenib—liver cancer	0.00546	0.00549	CcSEcCtD
Naratriptan—Dermatitis atopic—Doxorubicin—liver cancer	0.00541	0.00544	CcSEcCtD
Naratriptan—Neuritis—Doxorubicin—liver cancer	0.00537	0.0054	CcSEcCtD
Naratriptan—Glycosuria—Epirubicin—liver cancer	0.00535	0.00537	CcSEcCtD
Naratriptan—Stinging—Epirubicin—liver cancer	0.00535	0.00537	CcSEcCtD
Naratriptan—Angiopathy—Sorafenib—liver cancer	0.00534	0.00537	CcSEcCtD
Naratriptan—Immune system disorder—Sorafenib—liver cancer	0.00532	0.00534	CcSEcCtD
Naratriptan—Scotoma—Doxorubicin—liver cancer	0.00528	0.0053	CcSEcCtD
Naratriptan—Arrhythmia—Sorafenib—liver cancer	0.00526	0.00528	CcSEcCtD
Naratriptan—Alopecia—Sorafenib—liver cancer	0.0052	0.00523	CcSEcCtD
Naratriptan—Blood disorder—Epirubicin—liver cancer	0.00519	0.00521	CcSEcCtD
Naratriptan—Erythema—Sorafenib—liver cancer	0.00512	0.00515	CcSEcCtD
Naratriptan—Feeling hot—Doxorubicin—liver cancer	0.00511	0.00513	CcSEcCtD
Naratriptan—Hyperaesthesia—Doxorubicin—liver cancer	0.00511	0.00513	CcSEcCtD
Naratriptan—Almotriptan—CYP2E1—liver cancer	0.00506	1	CrCbGaD
Naratriptan—Stinging—Doxorubicin—liver cancer	0.00495	0.00497	CcSEcCtD
Naratriptan—Glycosuria—Doxorubicin—liver cancer	0.00495	0.00497	CcSEcCtD
Naratriptan—Muscle spasms—Sorafenib—liver cancer	0.00493	0.00495	CcSEcCtD
Naratriptan—Blood disorder—Doxorubicin—liver cancer	0.0048	0.00482	CcSEcCtD
Naratriptan—Ventricular extrasystoles—Epirubicin—liver cancer	0.0048	0.00482	CcSEcCtD
Naratriptan—Anaemia—Sorafenib—liver cancer	0.00474	0.00476	CcSEcCtD
Naratriptan—Syncope—Sorafenib—liver cancer	0.00459	0.00462	CcSEcCtD
Naratriptan—Ulcer—Epirubicin—liver cancer	0.00458	0.0046	CcSEcCtD
Naratriptan—Bone pain—Epirubicin—liver cancer	0.00452	0.00454	CcSEcCtD
Naratriptan—Loss of consciousness—Sorafenib—liver cancer	0.0045	0.00453	CcSEcCtD
Naratriptan—Cough—Sorafenib—liver cancer	0.00447	0.00449	CcSEcCtD
Naratriptan—Inflammation—Epirubicin—liver cancer	0.00447	0.00449	CcSEcCtD
Naratriptan—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00444	0.00446	CcSEcCtD
Naratriptan—Coordination abnormal—Epirubicin—liver cancer	0.00441	0.00443	CcSEcCtD
Naratriptan—Myalgia—Sorafenib—liver cancer	0.00436	0.00438	CcSEcCtD
Naratriptan—Arthralgia—Sorafenib—liver cancer	0.00436	0.00438	CcSEcCtD
Naratriptan—Vaginal inflammation—Epirubicin—liver cancer	0.00433	0.00435	CcSEcCtD
Naratriptan—Ventricular tachycardia—Epirubicin—liver cancer	0.00433	0.00435	CcSEcCtD
Naratriptan—Dry mouth—Sorafenib—liver cancer	0.00427	0.00429	CcSEcCtD
Naratriptan—Ulcer—Doxorubicin—liver cancer	0.00424	0.00426	CcSEcCtD
Naratriptan—Cystitis noninfective—Epirubicin—liver cancer	0.00423	0.00425	CcSEcCtD
Naratriptan—Bone pain—Doxorubicin—liver cancer	0.00418	0.0042	CcSEcCtD
Naratriptan—Cystitis—Epirubicin—liver cancer	0.00418	0.0042	CcSEcCtD
Naratriptan—Anaphylactic shock—Sorafenib—liver cancer	0.00418	0.0042	CcSEcCtD
Naratriptan—Infection—Sorafenib—liver cancer	0.00415	0.00418	CcSEcCtD
Naratriptan—Inflammation—Doxorubicin—liver cancer	0.00413	0.00415	CcSEcCtD
Naratriptan—Shock—Sorafenib—liver cancer	0.00411	0.00413	CcSEcCtD
Naratriptan—Fluid retention—Epirubicin—liver cancer	0.00411	0.00413	CcSEcCtD
Naratriptan—Nervous system disorder—Sorafenib—liver cancer	0.0041	0.00412	CcSEcCtD
Naratriptan—Thrombocytopenia—Sorafenib—liver cancer	0.00409	0.00411	CcSEcCtD
Naratriptan—Vaginal infection—Epirubicin—liver cancer	0.00409	0.00411	CcSEcCtD
Naratriptan—Coordination abnormal—Doxorubicin—liver cancer	0.00408	0.0041	CcSEcCtD
Naratriptan—Skin disorder—Sorafenib—liver cancer	0.00406	0.00408	CcSEcCtD
Naratriptan—Ventricular tachycardia—Doxorubicin—liver cancer	0.00401	0.00403	CcSEcCtD
Naratriptan—Vaginal inflammation—Doxorubicin—liver cancer	0.00401	0.00403	CcSEcCtD
Naratriptan—Dry eye—Epirubicin—liver cancer	0.004	0.00402	CcSEcCtD
Naratriptan—Oesophagitis—Epirubicin—liver cancer	0.00396	0.00398	CcSEcCtD
Naratriptan—Bladder pain—Epirubicin—liver cancer	0.00392	0.00394	CcSEcCtD
Naratriptan—Cystitis noninfective—Doxorubicin—liver cancer	0.00391	0.00393	CcSEcCtD
Naratriptan—Cystitis—Doxorubicin—liver cancer	0.00387	0.00389	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00381	0.00383	CcSEcCtD
Naratriptan—Fluid retention—Doxorubicin—liver cancer	0.0038	0.00382	CcSEcCtD
Naratriptan—Vaginal infection—Doxorubicin—liver cancer	0.00378	0.0038	CcSEcCtD
Naratriptan—Dyspnoea—Sorafenib—liver cancer	0.00373	0.00375	CcSEcCtD
Naratriptan—Dry eye—Doxorubicin—liver cancer	0.0037	0.00372	CcSEcCtD
Naratriptan—Oesophagitis—Doxorubicin—liver cancer	0.00366	0.00368	CcSEcCtD
Naratriptan—Bladder pain—Doxorubicin—liver cancer	0.00362	0.00364	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Sorafenib—liver cancer	0.00361	0.00363	CcSEcCtD
Naratriptan—Fatigue—Sorafenib—liver cancer	0.0036	0.00362	CcSEcCtD
Naratriptan—Photosensitivity—Epirubicin—liver cancer	0.00358	0.0036	CcSEcCtD
Naratriptan—Pain—Sorafenib—liver cancer	0.00358	0.00359	CcSEcCtD
Naratriptan—Constipation—Sorafenib—liver cancer	0.00358	0.00359	CcSEcCtD
Naratriptan—Vascular purpura—Epirubicin—liver cancer	0.00351	0.00353	CcSEcCtD
Naratriptan—Eye pain—Epirubicin—liver cancer	0.00348	0.0035	CcSEcCtD
Naratriptan—Urticaria—Sorafenib—liver cancer	0.00332	0.00334	CcSEcCtD
Naratriptan—Photosensitivity—Doxorubicin—liver cancer	0.00331	0.00333	CcSEcCtD
Naratriptan—Body temperature increased—Sorafenib—liver cancer	0.00331	0.00332	CcSEcCtD
Naratriptan—Purpura—Epirubicin—liver cancer	0.00326	0.00328	CcSEcCtD
Naratriptan—Vascular purpura—Doxorubicin—liver cancer	0.00325	0.00327	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Epirubicin—liver cancer	0.00325	0.00326	CcSEcCtD
Naratriptan—Eye pain—Doxorubicin—liver cancer	0.00322	0.00324	CcSEcCtD
Naratriptan—Cerebrovascular accident—Epirubicin—liver cancer	0.00321	0.00322	CcSEcCtD
Naratriptan—Migraine—Epirubicin—liver cancer	0.00309	0.00311	CcSEcCtD
Naratriptan—Hypersensitivity—Sorafenib—liver cancer	0.00308	0.0031	CcSEcCtD
Naratriptan—Purpura—Doxorubicin—liver cancer	0.00302	0.00303	CcSEcCtD
Naratriptan—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00301	0.00302	CcSEcCtD
Naratriptan—Asthenia—Sorafenib—liver cancer	0.003	0.00302	CcSEcCtD
Naratriptan—Cerebrovascular accident—Doxorubicin—liver cancer	0.00297	0.00298	CcSEcCtD
Naratriptan—Pruritus—Sorafenib—liver cancer	0.00296	0.00297	CcSEcCtD
Naratriptan—Dehydration—Epirubicin—liver cancer	0.00292	0.00294	CcSEcCtD
Naratriptan—Liver function test abnormal—Epirubicin—liver cancer	0.0029	0.00292	CcSEcCtD
Naratriptan—Dry skin—Epirubicin—liver cancer	0.00288	0.0029	CcSEcCtD
Naratriptan—Migraine—Doxorubicin—liver cancer	0.00286	0.00288	CcSEcCtD
Naratriptan—Diarrhoea—Sorafenib—liver cancer	0.00286	0.00288	CcSEcCtD
Naratriptan—Gastritis—Epirubicin—liver cancer	0.00278	0.0028	CcSEcCtD
Naratriptan—Dizziness—Sorafenib—liver cancer	0.00276	0.00278	CcSEcCtD
Naratriptan—Asthma—Epirubicin—liver cancer	0.00272	0.00273	CcSEcCtD
Naratriptan—Dehydration—Doxorubicin—liver cancer	0.00271	0.00272	CcSEcCtD
Naratriptan—Liver function test abnormal—Doxorubicin—liver cancer	0.00269	0.0027	CcSEcCtD
Naratriptan—Dry skin—Doxorubicin—liver cancer	0.00267	0.00268	CcSEcCtD
Naratriptan—Vomiting—Sorafenib—liver cancer	0.00266	0.00267	CcSEcCtD
Naratriptan—Angina pectoris—Epirubicin—liver cancer	0.00265	0.00266	CcSEcCtD
Naratriptan—Rash—Sorafenib—liver cancer	0.00264	0.00265	CcSEcCtD
Naratriptan—Dermatitis—Sorafenib—liver cancer	0.00263	0.00265	CcSEcCtD
Naratriptan—Headache—Sorafenib—liver cancer	0.00262	0.00263	CcSEcCtD
Naratriptan—Bronchitis—Epirubicin—liver cancer	0.00261	0.00263	CcSEcCtD
Naratriptan—Gastritis—Doxorubicin—liver cancer	0.00257	0.00259	CcSEcCtD
Naratriptan—Asthma—Doxorubicin—liver cancer	0.00251	0.00253	CcSEcCtD
Naratriptan—Pollakiuria—Epirubicin—liver cancer	0.00251	0.00252	CcSEcCtD
Naratriptan—Nausea—Sorafenib—liver cancer	0.00248	0.0025	CcSEcCtD
Naratriptan—Photosensitivity reaction—Epirubicin—liver cancer	0.00248	0.00249	CcSEcCtD
Naratriptan—Hyperglycaemia—Epirubicin—liver cancer	0.00245	0.00246	CcSEcCtD
Naratriptan—Angina pectoris—Doxorubicin—liver cancer	0.00245	0.00246	CcSEcCtD
Naratriptan—Pneumonia—Epirubicin—liver cancer	0.00244	0.00245	CcSEcCtD
Naratriptan—Drowsiness—Epirubicin—liver cancer	0.00242	0.00244	CcSEcCtD
Naratriptan—Bronchitis—Doxorubicin—liver cancer	0.00242	0.00243	CcSEcCtD
Naratriptan—Neuropathy peripheral—Epirubicin—liver cancer	0.00237	0.00239	CcSEcCtD
Naratriptan—Sweating—Epirubicin—liver cancer	0.00232	0.00233	CcSEcCtD
Naratriptan—Pollakiuria—Doxorubicin—liver cancer	0.00232	0.00233	CcSEcCtD
Naratriptan—Photosensitivity reaction—Doxorubicin—liver cancer	0.00229	0.00231	CcSEcCtD
Naratriptan—Sinusitis—Epirubicin—liver cancer	0.00227	0.00228	CcSEcCtD
Naratriptan—Hyperglycaemia—Doxorubicin—liver cancer	0.00227	0.00228	CcSEcCtD
Naratriptan—Pneumonia—Doxorubicin—liver cancer	0.00225	0.00227	CcSEcCtD
Naratriptan—Drowsiness—Doxorubicin—liver cancer	0.00224	0.00225	CcSEcCtD
Naratriptan—Bradycardia—Epirubicin—liver cancer	0.00221	0.00223	CcSEcCtD
Naratriptan—Neuropathy peripheral—Doxorubicin—liver cancer	0.0022	0.00221	CcSEcCtD
Naratriptan—Haemoglobin—Epirubicin—liver cancer	0.00219	0.0022	CcSEcCtD
Naratriptan—Haemorrhage—Epirubicin—liver cancer	0.00218	0.00219	CcSEcCtD
Naratriptan—Hypoaesthesia—Epirubicin—liver cancer	0.00216	0.00218	CcSEcCtD
Naratriptan—Sweating—Doxorubicin—liver cancer	0.00215	0.00216	CcSEcCtD
Naratriptan—Sinusitis—Doxorubicin—liver cancer	0.0021	0.00211	CcSEcCtD
Naratriptan—Bradycardia—Doxorubicin—liver cancer	0.00205	0.00206	CcSEcCtD
Naratriptan—Tinnitus—Epirubicin—liver cancer	0.00203	0.00204	CcSEcCtD
Naratriptan—Haemoglobin—Doxorubicin—liver cancer	0.00202	0.00203	CcSEcCtD
Naratriptan—Cardiac disorder—Epirubicin—liver cancer	0.00202	0.00203	CcSEcCtD
Naratriptan—Haemorrhage—Doxorubicin—liver cancer	0.00201	0.00202	CcSEcCtD
Naratriptan—Hypoaesthesia—Doxorubicin—liver cancer	0.002	0.00201	CcSEcCtD
Naratriptan—Angiopathy—Epirubicin—liver cancer	0.00197	0.00198	CcSEcCtD
Naratriptan—Immune system disorder—Epirubicin—liver cancer	0.00196	0.00197	CcSEcCtD
Naratriptan—Chills—Epirubicin—liver cancer	0.00195	0.00196	CcSEcCtD
Naratriptan—Arrhythmia—Epirubicin—liver cancer	0.00194	0.00195	CcSEcCtD
Naratriptan—Alopecia—Epirubicin—liver cancer	0.00192	0.00193	CcSEcCtD
Naratriptan—Erythema—Epirubicin—liver cancer	0.00189	0.0019	CcSEcCtD
Naratriptan—Tinnitus—Doxorubicin—liver cancer	0.00188	0.00189	CcSEcCtD
Naratriptan—Cardiac disorder—Doxorubicin—liver cancer	0.00187	0.00188	CcSEcCtD
Naratriptan—Angiopathy—Doxorubicin—liver cancer	0.00183	0.00184	CcSEcCtD
Naratriptan—Muscle spasms—Epirubicin—liver cancer	0.00182	0.00183	CcSEcCtD
Naratriptan—Immune system disorder—Doxorubicin—liver cancer	0.00182	0.00183	CcSEcCtD
Naratriptan—Chills—Doxorubicin—liver cancer	0.00181	0.00181	CcSEcCtD
Naratriptan—Arrhythmia—Doxorubicin—liver cancer	0.0018	0.00181	CcSEcCtD
Naratriptan—Vision blurred—Epirubicin—liver cancer	0.00178	0.00179	CcSEcCtD
Naratriptan—Alopecia—Doxorubicin—liver cancer	0.00178	0.00179	CcSEcCtD
Naratriptan—Ill-defined disorder—Epirubicin—liver cancer	0.00176	0.00177	CcSEcCtD
Naratriptan—Erythema—Doxorubicin—liver cancer	0.00175	0.00176	CcSEcCtD
Naratriptan—Anaemia—Epirubicin—liver cancer	0.00175	0.00176	CcSEcCtD
Naratriptan—Agitation—Epirubicin—liver cancer	0.00174	0.00175	CcSEcCtD
Naratriptan—Malaise—Epirubicin—liver cancer	0.00171	0.00172	CcSEcCtD
Naratriptan—Vertigo—Epirubicin—liver cancer	0.0017	0.00171	CcSEcCtD
Naratriptan—Syncope—Epirubicin—liver cancer	0.0017	0.00171	CcSEcCtD
Naratriptan—Muscle spasms—Doxorubicin—liver cancer	0.00168	0.00169	CcSEcCtD
Naratriptan—Palpitations—Epirubicin—liver cancer	0.00167	0.00168	CcSEcCtD
Naratriptan—Loss of consciousness—Epirubicin—liver cancer	0.00166	0.00167	CcSEcCtD
Naratriptan—Cough—Epirubicin—liver cancer	0.00165	0.00166	CcSEcCtD
Naratriptan—Vision blurred—Doxorubicin—liver cancer	0.00165	0.00166	CcSEcCtD
Naratriptan—Convulsion—Epirubicin—liver cancer	0.00164	0.00165	CcSEcCtD
Naratriptan—Ill-defined disorder—Doxorubicin—liver cancer	0.00163	0.00163	CcSEcCtD
Naratriptan—Anaemia—Doxorubicin—liver cancer	0.00162	0.00163	CcSEcCtD
Naratriptan—Arthralgia—Epirubicin—liver cancer	0.00161	0.00162	CcSEcCtD
Naratriptan—Myalgia—Epirubicin—liver cancer	0.00161	0.00162	CcSEcCtD
Naratriptan—Agitation—Doxorubicin—liver cancer	0.00161	0.00162	CcSEcCtD
Naratriptan—Anxiety—Epirubicin—liver cancer	0.00161	0.00161	CcSEcCtD
Naratriptan—Discomfort—Epirubicin—liver cancer	0.00159	0.0016	CcSEcCtD
Naratriptan—Malaise—Doxorubicin—liver cancer	0.00158	0.00159	CcSEcCtD
Naratriptan—Dry mouth—Epirubicin—liver cancer	0.00158	0.00158	CcSEcCtD
Naratriptan—Vertigo—Doxorubicin—liver cancer	0.00157	0.00158	CcSEcCtD
Naratriptan—Syncope—Doxorubicin—liver cancer	0.00157	0.00158	CcSEcCtD
Naratriptan—Confusional state—Epirubicin—liver cancer	0.00156	0.00157	CcSEcCtD
Naratriptan—Palpitations—Doxorubicin—liver cancer	0.00155	0.00156	CcSEcCtD
Naratriptan—Oedema—Epirubicin—liver cancer	0.00155	0.00155	CcSEcCtD
Naratriptan—Anaphylactic shock—Epirubicin—liver cancer	0.00155	0.00155	CcSEcCtD
Naratriptan—Loss of consciousness—Doxorubicin—liver cancer	0.00154	0.00155	CcSEcCtD
Naratriptan—Infection—Epirubicin—liver cancer	0.00154	0.00154	CcSEcCtD
Naratriptan—Cough—Doxorubicin—liver cancer	0.00153	0.00154	CcSEcCtD
Naratriptan—Shock—Epirubicin—liver cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Convulsion—Doxorubicin—liver cancer	0.00152	0.00153	CcSEcCtD
Naratriptan—Nervous system disorder—Epirubicin—liver cancer	0.00152	0.00152	CcSEcCtD
Naratriptan—Thrombocytopenia—Epirubicin—liver cancer	0.00151	0.00152	CcSEcCtD
Naratriptan—Skin disorder—Epirubicin—liver cancer	0.0015	0.00151	CcSEcCtD
Naratriptan—Hyperhidrosis—Epirubicin—liver cancer	0.00149	0.0015	CcSEcCtD
Naratriptan—Myalgia—Doxorubicin—liver cancer	0.00149	0.0015	CcSEcCtD
Naratriptan—Arthralgia—Doxorubicin—liver cancer	0.00149	0.0015	CcSEcCtD
Naratriptan—Anxiety—Doxorubicin—liver cancer	0.00149	0.00149	CcSEcCtD
Naratriptan—Discomfort—Doxorubicin—liver cancer	0.00147	0.00148	CcSEcCtD
Naratriptan—Dry mouth—Doxorubicin—liver cancer	0.00146	0.00147	CcSEcCtD
Naratriptan—Hypotension—Epirubicin—liver cancer	0.00144	0.00145	CcSEcCtD
Naratriptan—Confusional state—Doxorubicin—liver cancer	0.00144	0.00145	CcSEcCtD
Naratriptan—Oedema—Doxorubicin—liver cancer	0.00143	0.00144	CcSEcCtD
Naratriptan—Anaphylactic shock—Doxorubicin—liver cancer	0.00143	0.00144	CcSEcCtD
Naratriptan—Infection—Doxorubicin—liver cancer	0.00142	0.00143	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Naratriptan—Shock—Doxorubicin—liver cancer	0.00141	0.00141	CcSEcCtD
Naratriptan—Nervous system disorder—Doxorubicin—liver cancer	0.0014	0.00141	CcSEcCtD
Naratriptan—Thrombocytopenia—Doxorubicin—liver cancer	0.0014	0.00141	CcSEcCtD
Naratriptan—Skin disorder—Doxorubicin—liver cancer	0.00139	0.0014	CcSEcCtD
Naratriptan—Paraesthesia—Epirubicin—liver cancer	0.00139	0.00139	CcSEcCtD
Naratriptan—Hyperhidrosis—Doxorubicin—liver cancer	0.00138	0.00139	CcSEcCtD
Naratriptan—Dyspnoea—Epirubicin—liver cancer	0.00138	0.00138	CcSEcCtD
Naratriptan—Somnolence—Epirubicin—liver cancer	0.00137	0.00138	CcSEcCtD
Naratriptan—Hypotension—Doxorubicin—liver cancer	0.00134	0.00134	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Epirubicin—liver cancer	0.00133	0.00134	CcSEcCtD
Naratriptan—Fatigue—Epirubicin—liver cancer	0.00133	0.00134	CcSEcCtD
Naratriptan—Constipation—Epirubicin—liver cancer	0.00132	0.00133	CcSEcCtD
Naratriptan—Pain—Epirubicin—liver cancer	0.00132	0.00133	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.0013	0.00131	CcSEcCtD
Naratriptan—Paraesthesia—Doxorubicin—liver cancer	0.00128	0.00129	CcSEcCtD
Naratriptan—Dyspnoea—Doxorubicin—liver cancer	0.00127	0.00128	CcSEcCtD
Naratriptan—Feeling abnormal—Epirubicin—liver cancer	0.00127	0.00128	CcSEcCtD
Naratriptan—Somnolence—Doxorubicin—liver cancer	0.00127	0.00128	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00123	0.00124	CcSEcCtD
Naratriptan—Fatigue—Doxorubicin—liver cancer	0.00123	0.00124	CcSEcCtD
Naratriptan—Urticaria—Epirubicin—liver cancer	0.00123	0.00123	CcSEcCtD
Naratriptan—Pain—Doxorubicin—liver cancer	0.00122	0.00123	CcSEcCtD
Naratriptan—Constipation—Doxorubicin—liver cancer	0.00122	0.00123	CcSEcCtD
Naratriptan—Body temperature increased—Epirubicin—liver cancer	0.00122	0.00123	CcSEcCtD
Naratriptan—Feeling abnormal—Doxorubicin—liver cancer	0.00118	0.00118	CcSEcCtD
Naratriptan—Hypersensitivity—Epirubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Naratriptan—Urticaria—Doxorubicin—liver cancer	0.00114	0.00114	CcSEcCtD
Naratriptan—Body temperature increased—Doxorubicin—liver cancer	0.00113	0.00114	CcSEcCtD
Naratriptan—Asthenia—Epirubicin—liver cancer	0.00111	0.00111	CcSEcCtD
Naratriptan—Pruritus—Epirubicin—liver cancer	0.00109	0.0011	CcSEcCtD
Naratriptan—Diarrhoea—Epirubicin—liver cancer	0.00106	0.00106	CcSEcCtD
Naratriptan—Hypersensitivity—Doxorubicin—liver cancer	0.00105	0.00106	CcSEcCtD
Naratriptan—Asthenia—Doxorubicin—liver cancer	0.00103	0.00103	CcSEcCtD
Naratriptan—Dizziness—Epirubicin—liver cancer	0.00102	0.00103	CcSEcCtD
Naratriptan—Pruritus—Doxorubicin—liver cancer	0.00101	0.00102	CcSEcCtD
Naratriptan—Vomiting—Epirubicin—liver cancer	0.000982	0.000987	CcSEcCtD
Naratriptan—Diarrhoea—Doxorubicin—liver cancer	0.000978	0.000983	CcSEcCtD
Naratriptan—Rash—Epirubicin—liver cancer	0.000974	0.000979	CcSEcCtD
Naratriptan—Dermatitis—Epirubicin—liver cancer	0.000973	0.000978	CcSEcCtD
Naratriptan—Headache—Epirubicin—liver cancer	0.000968	0.000973	CcSEcCtD
Naratriptan—Dizziness—Doxorubicin—liver cancer	0.000945	0.00095	CcSEcCtD
Naratriptan—Nausea—Epirubicin—liver cancer	0.000918	0.000923	CcSEcCtD
Naratriptan—Vomiting—Doxorubicin—liver cancer	0.000909	0.000914	CcSEcCtD
Naratriptan—Rash—Doxorubicin—liver cancer	0.000902	0.000906	CcSEcCtD
Naratriptan—Dermatitis—Doxorubicin—liver cancer	0.000901	0.000905	CcSEcCtD
Naratriptan—Headache—Doxorubicin—liver cancer	0.000896	0.0009	CcSEcCtD
Naratriptan—Nausea—Doxorubicin—liver cancer	0.000849	0.000854	CcSEcCtD
